Advertisement
Screener

IMMUNITYBIO, INC. (IBRX) Investment Income, Interest and Dividend

2.4 / 5 stars · 47/97 Roast Me

IMMUNITYBIO, INC. Investment Income, Interest and Dividend

IMMUNITYBIO, INC. (IBRX) reported Investment Income, Interest and Dividend of $8.94 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-14.

Discontinued › Income Statement › Other Income

us-gaap:InvestmentIncomeInterestAndDividend · last filed 2021-05-14

  • IMMUNITYBIO, INC. investment income, interest and dividend for the quarter ending 2021-03-31 was $8.94M, a 11366.67% increase year-over-year.
  • IMMUNITYBIO, INC. investment income, interest and dividend for the quarter ending 2020-03-31 was $78.00K.
Period endInvestment Income, Interest and Dividend 3 monthInvestment Income, Interest and Dividend 12 month
2021-03-31$8.94M
10-Q · filed 2021-05-14
2020-12-31$2.44M
8-K/A · filed 2021-04-22
2020-03-31$78.00K
10-Q · filed 2021-05-14
2019-12-31$2.44M
8-K/A · filed 2021-04-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
REPLIGEN CORP (RGEN)United States$10.755B185.31
Immunovant, Inc. (IMVT)United States$7.028B-14.78
BIO-TECHNE Corp (TECH)United States$11.379B74.68
Twist Bioscience Corp (TWST)United States$11.540B-47.21
CG Oncology, Inc. (CGON)United States$6.095B-27.95
Scholar Rock Holding Corp (SRRK)United States$5.920B-16.37
CRISPR Therapeutics AG (CRSP)$5.390B-11.68